Accretion Nutrav

Why is Accretion Nutraveda Ltd falling/rising?

As of 06-Aug, Accretion Nutraveda Ltd's stock price is at Rs. 303.50, reflecting a 2.88% increase and strong performance with a +16.73% rise over the past month. Despite a significant drop in investor participation, the stock's positive momentum and technical indicators suggest continued strength.

As of 06-Aug, Accretion Nutraveda Ltd's stock price is rising, currently at Rs. 303.50, reflecting an increase of Rs. 8.5 or 2.88%. The stock has shown strong performance over the past week, with a return of +6.89%, significantly outperforming the Sensex, which only gained +1.32% during the same period. Over the past month, the stock has risen by +16.73%, while the Sensex has seen a modest increase of +0.86%.<BR><BR>Today, the stock reached a new 52-week and all-time high of Rs. 303.50, indicating positive momentum. Despite opening with a loss of -4.05%, the stock managed to recover and achieve an intraday high, demonstrating resilience. Additionally, it has been gaining for the last two days, with a total return of 7.05% in that timeframe.<BR><BR>Moreover, Accretion Nutraveda Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive technical indicator. However, it is worth noting that there has been a significant drop in investor participation, with delivery volume on 05 Aug falling by -95.28% compared to the 5-day average. Despite this, the stock remains liquid enough for trading.<BR><BR>In summary, the combination of recent price gains, strong performance relative to the benchmark, and reaching a new high contributes to the rising stock price of Accretion Nutraveda Ltd.

Which are the latest news on Accretion Nutrav?

What does Accretion Nutrav do?

Accretion Nutraveda Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 2021 and converted to a Public Limited Company in 2025. It currently has no available revenue or profit data, with a market cap of INR 188 Cr and a P/E ratio of 37.00.

Overview:<BR>Accretion Nutraveda Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History:<BR>Accretion Nutraveda Ltd was incorporated as a Private Limited Company on March 16, 2021, and later converted to a Public Limited Company on May 2, 2025. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 188 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 37.00<BR>Industry P/E: 34<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.00<BR>Return on Equity: 0.00%<BR>Price to Book: 0.00<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Accretion Nutrav?

As of 10th June, Accretion Nutraveda Ltd has a market capitalization of 188.00 Cr, categorized as a Micro Cap. There is no valid financial data available for net sales, net profit, or balance sheet metrics for the latest periods.

As of 10th June, <BR><BR>Market Cap: Accretion Nutraveda Ltd has a market capitalization of 188.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: There is no valid balance sheet data available for the latest annual period, including values for Shareholder's Funds and Total Assets.

Who are the peers of the Accretion Nutrav?

Accretion Nutrav's peers include Kerala Ayurveda, Nectar Lifesci., Syschem (India), Brooks Lab., Oxygenta Pharma, Coral Labs., Sanjiv.Parant., and Natural Capsules. Management risks vary, with good ratings for Sanjiv.Parant. and Syschem (India), while 1-year returns range from -64.41% for Kerala Ayurveda to 427.17% for Guj. Inject(Ker).

Peers: The peers of Accretion Nutrav are Kerala Ayurveda, Nectar Lifesci., Syschem (India), Brooks Lab., Oxygenta Pharma, Coral Labs., Sanjiv.Parant., Natural Capsules.<BR><BR>Quality Snapshot: Below Average management risk is observed at Kerala Ayurveda, Syschem (India), Brooks Lab., Coral Labs., and Natural Capsules, while Average management risk is found at Nectar Lifesci. Good management risk is noted at Sanjiv.Parant. For growth, Good growth is seen at Syschem (India) and Sanjiv.Parant., while Below Average growth is present at Kerala Ayurveda, Nectar Lifesci., Brooks Lab., Oxygenta Pharma, Coral Labs., and Natural Capsules. In terms of Capital Structure, Excellent capital structure is noted at Coral Labs., while Good capital structure is found at Syschem (India) and Sanjiv.Parant., with Below Average capital structure at the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Guj. Inject(Ker) at 427.17%, while the peer with the lowest 1-year return is Kerala Ayurveda at -64.41%. Accretion Nutrav's 1-year return is not available for comparison. Additionally, several peers, including Oxygenta Pharma, Sanjiv.Parant., and Natural Capsules, have negative six-month returns.

When is the next results date for Accretion Nutraveda Ltd?

The next results date for Accretion Nutraveda Ltd is 08 May 2026.

The next results date for Accretion Nutraveda Ltd is scheduled for 08 May 2026.